There's two issues, success rate (about 5%) and time ... even if it is successful in humans, it will be 5 to 10 years before it's available (and 20-30 before it's affordable)
This is not being a contrarian, but a realist.
This is not being a contrarian, but a realist.
Not if pharma execs and shareholders have anything to say about that